The study provides a fuller picture of the genetics and biological processes underlying type 2 diabetes, with some clear patterns emerging.
The international team, led by researchers from the University of Oxford, the Broad Institute of Harvard and MIT, and the University of Michigan, Ann Arbor, used a new DNA chip to probe deeper into the genetic variations that commonly occur in our DNA and which may have some connection to type 2 diabetes.
Their findings are published in the journal Nature Genetics.
'The ten gene regions we have shown to be associated with type 2 diabetes are taking us nearer a biological understanding of the disease,' says principal investigator Professor Mark McCarthy of the Wellcome Trust Centre for Human Genetics at the University of Oxford. 'It is hard to come up with new drugs for diabetes without first having an understanding of which biological processes in the body to target. This work is taking us closer to that goal.'
Approximately 2.9 million people are affected by diabetes in the UK, and there are thought to be perhaps a further 850,000 people with undiagnosed diabetes. Left untreated, diabetes can cause many different health problems including heart disease, stroke, nerve damage and blindness. Even a mildly raised glucose level can have damaging effects in the long-term.
Type 2 diabetes is by far the most common form of the disease. In the UK, about 90% of all adults with diabetes have type 2 diabetes. It occurs when the body does not produce enough insulin to control the level of glucose in the blood, and when the body no longer reacts effectively to the insulin that is produced.
The researchers analysed DNA from almost 35,000 people with type 2 diabetes and approximately 115,000 people without, identifying 10 new gene regions where DNA changes could be reliably linked to risk of the disease. Two of these showed different effects in men and women, one linked to greater diabetes risk in men and the other in women.
With over 60 genes and gene regions now linked to type 2 diabetes, the researchers were able to find patterns in the types of genes implicated in the disease. Although each individual gene variant has only a small influence on people's overall risk of diabetes, the types of genes involved are giving new insight into the biology behind diabetes.
Professor Mark McCarthy says: 'By looking at all 60 or so gene regions together we can look for signatures of the type of genes that influence the risk of type 2 diabetes.
'We see genes involved in controlling the process of cell growth, division and ageing, particularly those that are active in the pancreas where insulin is produced. We see genes involved in pathways through which the body's fat cells can influence biological processes elsewhere in the body. And we see a set of transcription factor genes – genes that help control what other genes are active.'
While gene association studies have been successful in finding DNA regions that can be reliably linked to type 2 diabetes, it can be hard to tie down which gene and what exact DNA change is responsible.
Professor McCarthy and colleagues' next step is to get complete information about genetic changes driving type 2 diabetes by sequencing people's DNA in full.
He is currently leading a study from Oxford University that, with collaborators in the US and Europe, has sequenced the entire genomes of 1400 people with diabetes and 1400 people without. First results will be available next year.
'Now we have the ability to do a complete job, capturing all genetic variation linked to type 2 diabetes,' says Professor McCarthy, a Wellcome Trust Senior Investigator. 'Not only will we be able to look for signals we've so far missed, but we will also be able to pinpoint which individual DNA change is responsible. These genome sequencing studies will really help us push forward towards a more complete biological understanding of diabetes.'
Notes to editors
*It is possible to see how some types of genes identified in these studies could be involved in type 2 diabetes.
For example, one feature of type 2 diabetes is that the insulin-producing cells in the pancreas can no longer produce enough of the hormone to control glucose levels in the blood. However, it is not known whether this is because there are fewer cells left to respond to the demand, or there are plenty of cells but they don't respond as much, or both. Cell cycle genes, which control the growth, development and death of cells, could well play a role here.
Obesity is known to be a major risk factor for diabetes. Becoming obese tends to result in the body becoming less responsive to the insulin it produces. While fat must be important in this, it is the liver and muscle where the insulin resistance has an effect. The involvement of processes where fat cells communicate with other parts of the body, as suggested by the genetics findings, could explain how this occurs.
* The researchers show that the data emerging from gene association studies is consistent with the genetic contribution to diabetes being made up of many, many common gene variants each having a small effect. This is more likely than there being a significant contribution from unknown rare genetic variants that only a few people have, but which confer a much greater risk of diabetes.
Professor McCarthy says: 'We now have strong evidence that there is a long tail of further common gene variations beyond those we have identified so far. The 60 or so we know about will be the gene variants with strongest effects on risk of type 2 diabetes. But there are likely to be tens, hundreds, possibly even thousands more genes having smaller and smaller influences on development of the condition.'
* The paper 'Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes' is to be published in the journal Nature Genetics with an embargo of 13:00 US Eastern Time on Sunday 12 August 2012.
* The study was carried out by a very large international team of researchers from institutions across Europe, North America, Australia, Singapore and Pakistan. Funding came from many sources. The main funders for the Oxford University researchers were the Wellcome Trust, European Union, the National Institutes of Health in the USA, and the UK Medical Research Council.
* Oxford University's Medical Sciences Division is one of the largest biomedical research centres in Europe, with over 2,500 people involved in research and more than 2,800 students. The University is rated the best in the world for medicine, and it is home to the UK's top-ranked medical school.
From the genetic and molecular basis of disease to the latest advances in neuroscience, Oxford is at the forefront of medical research. It has one of the largest clinical trial portfolios in the UK and great expertise in taking discoveries from the lab into the clinic. Partnerships with the local NHS Trusts enable patients to benefit from close links between medical research and healthcare delivery.
A great strength of Oxford medicine is its long-standing network of clinical research units in Asia and Africa, enabling world-leading research on the most pressing global health challenges such as malaria, TB, HIV/AIDS and flu. Oxford is also renowned for its large-scale studies which examine the role of factors such as smoking, alcohol and diet on cancer, heart disease and other conditions.
* The Wellcome Trust is a global charitable foundation dedicated to achieving extraordinary improvements in human and animal health. It supports the brightest minds in biomedical research and the medical humanities. The Trust's breadth of support includes public engagement, education and the application of research to improve health. It is independent of both political and commercial interests.
University of Oxford press office | EurekAlert!
Further reports about: > Broad Institute > DNA > Genetics > McCarthy > Medical Wellness > Nature Genetics > Nature Immunology > Oxford > biomedical research > fat cells > gene variant > genetic variant > genetic variation > health problem > heart disease > insulin-producing cell > medical research > risk of diabetes > type 2 diabetes
One step closer to reality
20.04.2018 | Max-Planck-Institut für Entwicklungsbiologie
The dark side of cichlid fish: from cannibal to caregiver
20.04.2018 | Veterinärmedizinische Universität Wien
University of Connecticut researchers have created a biodegradable composite made of silk fibers that can be used to repair broken load-bearing bones without the complications sometimes presented by other materials.
Repairing major load-bearing bones such as those in the leg can be a long and uncomfortable process.
Study published in the journal ACS Applied Materials & Interfaces is the outcome of an international effort that included teams from Dresden and Berlin in Germany, and the US.
Scientists at the Helmholtz-Zentrum Dresden-Rossendorf (HZDR) together with colleagues from the Helmholtz-Zentrum Berlin (HZB) and the University of Virginia...
Novel highly efficient and brilliant gamma-ray source: Based on model calculations, physicists of the Max PIanck Institute for Nuclear Physics in Heidelberg propose a novel method for an efficient high-brilliance gamma-ray source. A giant collimated gamma-ray pulse is generated from the interaction of a dense ultra-relativistic electron beam with a thin solid conductor. Energetic gamma-rays are copiously produced as the electron beam splits into filaments while propagating across the conductor. The resulting gamma-ray energy and flux enable novel experiments in nuclear and fundamental physics.
The typical wavelength of light interacting with an object of the microcosm scales with the size of this object. For atoms, this ranges from visible light to...
Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.
Certain mesenchymal stem/stromal cells from the bone marrow of adults are considered extremely promising for skeletal tissue regeneration. These adult stem...
In the fight against cancer, scientists are developing new drugs to hit tumor cells at so far unused weak points. Such a “sore spot” is the protein complex...
13.04.2018 | Event News
12.04.2018 | Event News
09.04.2018 | Event News
20.04.2018 | Physics and Astronomy
20.04.2018 | Interdisciplinary Research
20.04.2018 | Physics and Astronomy